Examkin

Question

Difficulty: Very hardPreventive Care and Immunizations

Match each pediatric patient presenting for a clinical visit with the most appropriate next step in their preventive care or immunization management.

  • A 12-month-old boy with severe congenital T-cell lymphopenia (e.g., severe combined immunodeficiency) presenting for a well-child visit.Withhold all live-attenuated vaccines, including the measles, mumps, and rubella (MMR) and varicella vaccines.
  • A 12-month-old girl whose mother received high-dose infliximab therapy throughout the third trimester of pregnancy, presenting for routine immunizations.Administer the MMR and varicella vaccines without delay, as the infant is past the contraindication window for maternal biologic exposure.
  • A 15-month-old girl presenting for routine immunizations whose household sibling recently underwent a bone marrow transplant and is severely immunocompromised.Administer the MMR and varicella vaccines, but strictly avoid the live-attenuated influenza vaccine (LAIV).
  • A 4-month-old boy who was treated with intravenous immune globulin (IVIG) for Kawasaki disease 4 weeks ago, presenting for routine immunizations.Administer the scheduled oral rotavirus vaccine, as prior antibody therapy does not interfere with its mucosal efficacy.
  • A 7-year-old boy with no prior immunizations presenting with a deep, dirty puncture wound from a rusted metal fence.Administer the Tdap vaccine and tetanus immune globulin (TIG) concurrently.

Answer

The correct matches align specific high-risk pediatric scenarios with their respective modified immunization or post-exposure prophylaxis protocols based on altered immunocompetence, household exposures, and age constraints.
Each match correctly applies ACIP and Bright Futures guidelines for exceptional pediatric populations. The rules for live vaccines depend heavily on the mechanism of immunosuppression (cellular vs. passive antibody), the route of vaccine administration (parenteral vs. mucosal), and the exact timeline of exposure.

Step-by-Step Solution

1
Evaluate the 12-month-old with severe T-cell lymphopenia.
Match with withholding all live-attenuated vaccines.
Patients with severe cellular immunodeficiency cannot mount an adequate response to, and cannot safely clear, the attenuated viruses in live vaccines. Administration can cause fatal disseminated vaccine-strain infection.
2
Evaluate the 12-month-old with in utero infliximab exposure.
Match with administering MMR and varicella vaccines without delay.
IgG monoclonal antibodies cross the placenta. Infants are considered immunosuppressed for the first 6 months of life, contraindicating early live vaccines like rotavirus. At 12 months, the infant's immune system is normal, and MMR/varicella are safe.
3
Evaluate the 15-month-old sibling of a bone marrow transplant recipient.
Match with administering MMR/varicella but avoiding LAIV.
To protect immunocompromised family members, healthy contacts should be fully immunized, including with MMR and varicella. The only exception is LAIV (nasal flu spray), which is contraindicated because the attenuated virus can be shed and transmitted to the transplant recipient.
4
Evaluate the 4-month-old who received IVIG 4 weeks ago.
Match with administering the scheduled oral rotavirus vaccine.
IVIG provides passive serum IgG that interferes with injected live vaccines (MMR, varicella), necessitating a delay. It does not interfere with mucosal IgA responses in the gastrointestinal tract, so the live oral rotavirus vaccine is given on its strict age-based schedule.
5
Evaluate the completely unimmunized 7-year-old with a dirty wound.
Match with administering Tdap and TIG.
Unknown or <3 doses of tetanus toxoid plus a dirty wound requires both active (vaccine) and passive (TIG) prophylaxis. At age 7 years, the correct formulation is Tdap, as DTaP is contraindicated at age 7 and older.

Key Concept

Complex immunization management requires understanding the distinctions between cellular vs. humoral immunodeficiency, parenteral vs. mucosal live vaccines, and strict age cutoffs for specific vaccine formulations.
Rate this question

Topics

Preventive Care and Immunizations

More questions from this topic